Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation.
Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes.
Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.
Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double blind, randomized controlled non-inferiority trial.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity.
Translational utility of experimental autoimmune encephalomyelitis: recent developments.
Clinical Neurophysiology in multiple sclerosis - From diagnostic tool to biomarker.
Heterodimerization of p45-p75 Modulates p75 Signaling: Structural Basis and Mechanism of Action.
Histamine h3 receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.
Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.
Gamma Knife rhizotomy-induced histopathology in multiple sclerosis-related trigeminal neuralgia.
Th17 cells in autoimmune diseases.
Translating Neurogenomics into New Medicines.
Quantifying Demyelination in NK venom treated nerve using its electric circuit model.
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
Pages
« first
‹ previous
…
646
647
648
649
650
651
652
653
654
…
next ›
last »